Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 5/20 | 0.39 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1170371 | 1.00 | TP53 (0.52) | TP53EPHX1KDM4EGMNNLMNA | |
| SCHEMBL22227354 | 1.00 | TP53 (0.52) | TP53EPHX1KDM4EGMNNLMNA | |
| SCHEMBL1079175 | 1.00 | — | — | |
| SCHEMBL14434506 | 0.97 | — | — | |
| SCHEMBL595080 | 0.97 | — | — | |
| SCHEMBL1444705 | 0.90 | — | — | |
| SCHEMBL381423 | 0.83 | — | — | |
| SCHEMBL14733998 | 0.83 | — | — | |
| SCHEMBL14305362 | 0.80 | TP53 (0.41) | TP53EPHX1KDM4EGMNNLMNA | |
| SCHEMBL14434357 | 0.78 | TP53 (0.39) | TP53EPHX1KDM4EGMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116802227-A | Curable silicone coating comprising non-organotin catalyst | 迈图高新材料公司 | 2023-09-22 | — | — | CN | disclosed |
| US-8328882-B2 | Gentle dyeing and lightening agents having improved lightening power | HENKEL AG & CO. KGAA (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20120171135-A1 | Gentle Dyeing and Lightening Agents Having Improved Lightening Power | HENKEL AG & CO. KGAA (DE) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120171135-A1 | Gentle Dyeing and Lightening Agents Having Improved Lightening Power | LMNB1, LMNB2, LMNA | TP53 3541/4885EPHX1 1946/4885KDM4E 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.